Valeo Pharmainc (VPH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2020 | 07-2020 | 04-2020 | 01-2020 | 10-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,836 | 68 | 0 | 0 | 335 |
| Receivables | 1,220 | 1,004 | 1,432 | 799 | 613 |
| Inventories | 881 | 629 | 470 | 515 | 561 |
| TOTAL | $5,410 | $1,905 | $1,990 | $1,413 | $1,651 |
| Non-Current Assets | |||||
| PPE Net | 605 | 571 | 597 | 622 | 296 |
| Intangibles | 4,948 | 4,621 | 4,484 | 4,371 | 3,860 |
| TOTAL | $5,553 | $5,192 | $5,081 | $4,993 | $4,156 |
| Total Assets | $10,963 | $7,097 | $7,071 | $6,406 | $5,807 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,158 | 1,537 | 1,065 | N/A |
| Accounts payable and accrued liabilities | 3,381 | 3,526 | 3,940 | 3,802 | 4,377 |
| Accrued Expenses | 103 | 101 | N/A | N/A | N/A |
| TOTAL | $4,278 | $5,652 | $6,200 | $5,477 | $4,477 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,967 | 2,947 | 1,842 | 1,411 | 1,001 |
| Other Non-Current Liabilities | 416 | 370 | 379 | 342 | 351 |
| TOTAL | $3,616 | $3,566 | $2,482 | $2,014 | $1,352 |
| Total Liabilities | $7,894 | $9,218 | $8,682 | $7,491 | $5,829 |
| Shareholders' Equity | |||||
| Common Shares | 15,024 | 9,371 | 8,794 | 8,820 | 8,829 |
| Retained earnings | -14,477 | -13,301 | -11,686 | -10,824 | -9,716 |
| Other shareholders' equity | 911 | 808 | 614 | 293 | 273 |
| TOTAL | $3,069 | $-2,121 | $-1,611 | $-1,085 | $-22 |
| Total Liabilities And Equity | $10,963 | $7,097 | $7,071 | $6,406 | $5,807 |